title: Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis.
abstract: Megakaryocytes release platelets into the bloodstream by elongating proplatelets. In this study, we showed that human megakaryocytes constitutively release Transforming Growth Factor β1 and express its receptors. Importantly, Transforming Growth Factor β1 downstream signaling, through SMAD2/3 phosphorylation, was shown to be active in megakaryocytes extending proplatelets, indicating a type of autocrine stimulation on megakaryocyte development. Furthermore, inactivation of Transforming Growth Factor β1 signaling, by the receptor inhibitors SB431542 and Stemolecule ALK5 inhibitor, determined a significant decrease in proplatelet formation. Recent studies indicated a crucial role of Transforming Growth Factor β1 in the pathogenesis of primary myelofibrosis. We demonstrated that primary myelofibrosis-derived megakaryocytes expressed increased levels of bioactive Transforming Growth Factor β1; however, higher levels of released Transforming Growth Factor β1 did not lead to enhanced activation of downstream pathways. Overall, these data propose Transforming Growth Factor β1 as a new element in the autocrine regulation of proplatelet formation in vitro. Despite the increase in Transforming Growth Factor β1 this mechanism seems to be preserved in primary myelofibrosis.
authors: Biotechnology Laboratories, Department of Molecular Medicine, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
authors: Stefania
authors: S
authors: Badalucco
authors: Christian Andrea
authors: CA
authors: Di Buduo
authors: Rita
authors: R
authors: Campanelli
authors: Isabella
authors: I
authors: Pallotta
authors: Paolo
authors: P
authors: Catarsi
authors: Vittorio
authors: V
authors: Rosti
authors: David L
authors: DL
authors: Kaplan
authors: Giovanni
authors: G
authors: Barosi
authors: Margherita
authors: M
authors: Massa
authors: Alessandra
authors: A
authors: Balduini
mesh_terms: D019898:Autocrine Communication; D001549:Benzamides / Q000494:pharmacology; D001792:Blood Platelets / Q000166:cytology / Q000378:metabolism; D015153:Blotting, Western; D002478:Cells, Cultured; D004149:Dioxoles / Q000494:pharmacology; D015870:Gene Expression; D006801:Humans; D008533:Megakaryocytes / Q000166:cytology / Q000378:metabolism*; D010766:Phosphorylation; D055728:Primary Myelofibrosis / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D000077293:Receptor, Transforming Growth Factor-beta Type I; D000077294:Receptor, Transforming Growth Factor-beta Type II; D018125:Receptors, Transforming Growth Factor beta / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics; D051899:Smad2 Protein / Q000378:metabolism; D051900:Smad3 Protein / Q000378:metabolism; D053773:Transforming Growth Factor beta1 / Q000235:genetics* / Q000378:metabolism
chemical_list: C459179:4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide; D001549:Benzamides; D004149:Dioxoles; D018125:Receptors, Transforming Growth Factor beta; C497782:SMAD2 protein, human; D051899:Smad2 Protein; D051900:Smad3 Protein; D053773:Transforming Growth Factor beta1; D017346:Protein Serine-Threonine Kinases; D000077293:Receptor, Transforming Growth Factor-beta Type I; D000077294:Receptor, Transforming Growth Factor-beta Type II; C000625841:TGFBR1 protein, human
references: Hematology Am Soc Hematol Educ Program. 2009;:147-52
references: 20008193
references: Blood. 1990 Oct 1;76(7):1315-22
references: 2207308
references: Haematologica. 2012 Nov;97(11):1657-65
references: 22689668
references: EMBO J. 2000 Apr 17;19(8):1745-54
references: 10775259
references: Oncogene. 2005 Aug 29;24(37):5751-63
references: 16123808
references: Cell Res. 2009 Jan;19(1):128-39
references: 19114990
references: J Clin Invest. 2004 Mar;113(5):676-85
references: 14991065
references: J Clin Invest. 2005 Dec;115(12):3348-54
references: 16322779
references: Cell Stem Cell. 2010 Mar 5;6(3):265-78
references: 20207229
references: Blood. 2009 Jul 30;114(5):937-51
references: 19357394
references: PLoS One. 2011;6(6):e21015
references: 21698292
references: Blood. 1999 Sep 15;94(6):1961-70
references: 10477725
references: Blood. 2003 Feb 15;101(4):1316-23
references: 12406876
references: PLoS One. 2012;7(7):e39796
references: 22792187
references: Blood. 2007 Aug 1;110(3):986-93
references: 17473062
references: Br J Haematol. 2004 Jan;124(2):211-20
references: 14687032